Interestingly, AKT-induced tamoxifen resistance is reversed by RRM2 inhibition in breast cancer (32), suggesting that RRM2 may participate in the chemotherapy resistance of cancer cells. The gene discussed is RRM2; the disease is breast carcinoma.